Fingerprint
Dive into the research topics of 'Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib
Robert Galvin, Adrienne L. Watson, David A. Largaespada, Nancy Ratner, Sara Osum, Christopher L. Moertel
Research output: Contribution to journal › Review article › peer-review
16
Scopus
citations